Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

150 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Australia's CSL reaffirms upbeat forecast; profit jumps
RE
CSL : Shareholder Meeting Document
PU
Domtar Corporation completed the acquisition of Resolute Forest Products Inc. from Fairfax Financial Holdings Limited, Chou Associates Management Inc., Dimensional Fund Advisors LP and others.
CI
Transcript : CSL Limited, H1 2023 Earnings Call, Feb 14, 2023
Australia's CSL Says 1st Half Profit Steady at Constant Currency
DJ
Australian biotech CSL profit jumps on post-lockdown revival
RE
CSL Announces Next CEO & Managing Director
PR
CSL Limited Announces Chief Executive Officer Changes
CI
CSL Limited Announces Management Changes
CI
Australia's CSL Ltd names insider Paul McKenzie as CEO
RE
CSL Appoints Chief Operating Officer as CEO, MD From March 2023
DJ
U.S. Food and Drug Administration approves CSL's HEMGENIX® (etranacogene dezaparvovec-drlb), the first gene therapy for hemophilia B
PR
Transcript : CSL Limited - Special Call
Australia's CSL raises annual profit forecast on Swiss acquisition
RE
Transcript : CSL Limited - Special Call
Transcript : CSL Limited - Shareholder/Analyst Call
CSL presents new research and development center in Marburg, Germany
AQ
CSL : Annual Report 2022
PU
CSL : Shareholder Meeting Document
PU
Transcript : CSL Limited, 2022 Earnings Call, Aug 17, 2022
Australia biotech giant CSL reports profit dip, flags cost spiral
RE
CSL : Announces Carbon Targets
PU
CSL Net Profit Falls, But Expects Growth For Coming Year
DJ
Transcript : UGI Corporation, Q3 2022 Earnings Call, Aug 04, 2022
Finalization of Vifor Pharma acquisition
BU
Domtar Corporation entered into an agreement to acquire Resolute Forest Products Inc. from Fairfax Financial Holdings Limited, Chou Associates Management Inc., Dimensional Fund Advisors LP and others for $2.5 billion.
CI
Australia biotech firm CSL says plasma business hit by Omicron, but demand robust
RE
Transcript : CSL Limited, H1 2022 Earnings Call, Feb 16, 2022
CSL 1st Half Net Profit Falls as Immunoglobulin Sales Decline
DJ
CSL : Half Year Results Investor Presentation
PU
CSL : Half Year Results Announcement
PU
Transcript : CSL Limited, Vifor Pharma AG - M&A Call
CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- 2nd Update
DJ
CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- Update
DJ
CSL : SWISS TENDER OFFER TO ACQUIRE 100% OF VIFOR PHARMA LTD
PU
CSL : Investor Presentation CSL Swiss Tender Acquisition of Vifor
PU
Australia's CSL to buy Swiss drugmaker Vifor for $11.7 bln
RE
CSL in Talks to Buy Vifor Pharma
CI
Transcript : CSL Limited - Special Call
Transcript : CSL Limited - Shareholder/Analyst Call
CSL : Annual Report
PU
CSL's Plasma Collections on Track to Exceed Pre-Pandemic Levels, CEO Says
DJ
Transcript : CSL Limited, 2021 Earnings Call, Aug 18, 2021
CSL : Results Announcement
PU
CSL : Results Presentation
PU
CSL Fiscal Year Net Profit Rises, But Expects Decline in Fiscal Year 2022
DJ
Transcript : BTB Real Estate Investment Trust - Shareholder/Analyst Call
UGI Corporation : Announces Executive Appointments for its Global LPG Line of Business
BU
UniQure N : CSL Behring Announces Closing of Global Commercialization and License Agreement with uniQure for etranacogene dezaparvovec
AQ
CSL : Behring Announces Agreement with uniQure
PU
No results for this search
  1. Stock Market
  2. Advanced search
  3. Paul Perreault
  4. News